文献速递主动脉疾病

胸主动脉腔内修复术后脊髓缺血的全国发病率、死亡结局及预测因素

National incidence, mortality outcomes, and predictors of spinal cord ischemia after thoracic endovascular aortic repair.
PubMed 文献 · J Vasc Surg · 2020-01-21

基于血管质量倡议(VQI)数据库2014年6月至2019年6月的11,473例胸主动脉腔内修复(TEVAR)手术,分析院内脊髓缺血(SCI)发生率为3.7%,其中暂时性1.6%、永久性2.1%。发生SCI者1年生存率显著低于无SCI者(65% vs 87%,P<.0001),永久性SCI者生存率更低(54% vs 暂时性80%,P<.0001)。研究首次建立了基于全国数据的术前SCI预测模型(AUC=0.72)。

要点

  • TEVAR术后院内SCI总发生率为3.7%,永久性SCI为2.1%。
  • 发生SCI者1年生存率仅65%,永久性SCI者更低至54%。
  • 术前预测因素包括远端锚定区5-10区、非择期手术、肌酐>1.38 mg/dL等。

核心结论

  • TEVAR术后SCI发生率为3.7%,与更差的总体生存相关,尤其是出院时未功能恢复者。
  • 本研究首次描述了基于全国数据的TEVAR术后SCI术前预测模型。

研究设计与样本

  • 回顾性分析VQI数据库2014年6月至2019年6月所有TEVAR手术,共11,473例。
  • 主要终点为院内SCI(新发神经功能缺损或瘫痪,非颅内疾病所致),功能结局由治疗医师判定。
  • 采用Kaplan-Meier分析和Cox比例风险模型评估SCI与生存的关联,逻辑回归模型筛选术前预测因素。

主要发现

  • 总体SCI发生率为3.7%(n=422/11,473),其中暂时性1.6%(n=179),永久性2.1%(n=243)。
  • 发生任何SCI者1年生存率65%,无SCI者87%(P<.0001);永久性SCI者1年生存率54%,暂时性SCI者80%(P<.0001)。
  • 疾病特异性SCI发生率:动脉瘤3.4%,夹层5.3%,夹层后动脉瘤4.1%,创伤1.1%,穿透性溃疡2.4%,壁内血肿5.7%,穿透性溃疡合并壁内血肿4.3%,主动脉血栓4.8%。

关键数值与推荐

  • 术前预测因素包括远端锚定区5至10区、非择期手术、肌酐>1.38 mg/dL、吸烟史、ASA分级、辅助操作、非白种人、术前高血压(AUC=0.72;Nagelkerke R2=0.06)。

临床怎么用

  • 应使用术前预测因素识别SCI高危患者,权衡SCI风险及其相关短期死亡风险与基础疾病风险。
  • 对高危患者应实施所有可用的辅助措施以降低SCI风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Spinal cord ischemia (SCI) is a dreaded complication of thoracic endovascular aortic repair (TEVAR). There are limited national data describing the incidence and influence of in-hospital SCI recovery on survival. Moreover, no robust preoperative SCI risk assessment models currently exist. The purpose of this analysis was to analyze the Vascular Quality Initiative to determine the national incidence, survival association, and preoperative predictors of SCI after TEVAR. METHODS: All Vascular Quality Initiative TEVAR procedures (June 2014-June 2019) were reviewed. The primary end point was development of in-hospital SCI, defined as any new neurologic deficit or paralysis not attributable to intracranial disease. Secondary end points were disease-specific SCI rates and long-term out-of-hospital survival. Functional outcomes (transient vs permanent SCI) were independently determined by treating physicians. Kaplan-Meier analysis and Cox proportional hazards methodology were used to assess the association of SCI with survival. A logistic regression model of candidate preoperative SCI predictors was created, and bootstrapped backward elimination (retaining predictors with ≥50% selection frequency) was used for model reduction. Model fit and performance statistics were validated by adjustment for Efron's optimism. RESULTS: The overall rate of SCI was 3.7% (n = 422/11,473; transient, 1.6% [n = 179]; permanent, 2.1% [n = 243]). Patients who developed any SCI had significantly lower Kaplan-Meier survival estimate compared with those without SCI (1-year survival: SCI, 65%; no SCI, 87%; P < .0001), and patients with permanent SCI had notably worse survival than patients with transient SCI (1-year survival: permanent SCI, 54%; transient SCI, 80%; P < .0001). Disease-specific incidence of any SCI was as follows: aneurysm, 3.4%; dissection, 5.3%; aneurysm from dissection, 4.1%; trauma, 1.1%; penetrating ulceration, 2.4%; intramural hematoma, 5.7%; penetrating ulceration and intramural hematoma, 4.3%; and aortic thrombus, 4.8%. Several factors were selected on multivariable analysis as the most robust preoperative predictors of any SCI, including distal landing zone 5 to zone 10, nonelective case, creatinine concentration >1.38 mg/dL, smoking history, American Society of Anesthesiologists class, adjunctive procedure, nonwhite race, and preoperative hypertension (area under the curve = 0.72; Nagelkerke R2 = 0.06). CONCLUSIONS: SCI is a devastating complication after TEVAR that is associated with worse overall survival, particularly when no functional recovery occurs by hospital discharge. Disease-specific, real-world benchmarks for SCI rates are provided that may inform quality initiatives focused on reducing this complication. Importantly, this analysis is the first description of a preoperative prediction model derived from national data for determining SCI risk after TEVAR. These predictors should be used to identify high-risk patients to balance the risk of SCI and its associated increased short-term mortality with the risk of the underlying disease. Furthermore, all available adjunctive measures should be implemented in these high-risk patients to reduce risk of SCI.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Scali ST, Giles KA, Wang GJ, et al. National incidence, mortality outcomes, and predictors of spinal cord ischemia after thoracic endovascular aortic repair. J Vasc Surg. 2020. PMID: 31980244. doi:10.1016/j.jvs.2019.09.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。